Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Green Tread Oy Ltd

Home Clinical Trial Sponsors and OrganizationsGreen Tread Oy Ltd

Green Tread Oy Ltd

Luostarinkatu 16, Naantali, Varsinais-Suomi, Finland

Also known as:

medicure

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

4

50.0%

Phase 3

3

37.5%

Phase 1

1

12.5%

Trial Status Distribution

Completed

5

62.5%

Recruiting

1

12.5%

Terminated

1

12.5%

Withdrawn

1

12.5%

Clinical Trials

Trials sponsored by this organization (8)

Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

Feb 202415 participants

Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function

Jan 201325 participants

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention

Apr 2012535 participants

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

May 200953 participants

A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG

Nov 20063,000 participants

MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)

Aug 2004160 participants

MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)

Apr 2004900 participants

Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations